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Abstract
This study investigates adaptation of ST406, a prevalent P. aeruginosa clone, present in
15% of chronically infected cystic fibrosis (CF) patients in the Netherlands, in a newly
infected CF patient during three years using whole genome sequencing (WGS), transcrip-
tomics, and phenotypic assays, including biofilm formation. WGS-based phylogeny demon-
strates that ST406 is genetically distinct from other reported CF related strains or epidemic
clones. Comparative genomic analysis of the early (S1) and late (S2) isolate yielded 42 sin-
gle nucleotide polymorphisms (SNPs) and 10 indels and a single 7 kb genomic fragment
only found in S2. Most SNPs and differentially expressed genes encoded proteins involved
in metabolism, secretion and signal transduction or transcription. SNPs were identified in
regulator genesmexT and exsA and coincided with differential gene expression ofmexE
andmexF, encoding the MexE/F efflux pump, genes encoding the type six secretion system
(T6SS) and type three secretion system (T3SS), which have also been previously impli-
cated in adaptation of other P. aeruginosa strains during chronic infection of CF lungs. The
observation that genetically different strains from different patients have accumulated simi-
lar genetic adaptations supports the concept of adaptive parallel evolution of P. aeruginosa
in chronically infected CF patients. Phenotypically, there was loss of biofilm maturation coin-
ciding with a significant lower level of transcription of both bfmR and bfmS during chronic
colonization. These data suggest that the high-prevalent Dutch CF clone ST406 displays
adaptation to the CF lung niche, which involves a limited number of mutations affecting reg-
ulators controlling biofilm formation and secretion and genes involved in metabolism. These
genes could provide good targets for anti-pseudomonal therapy.
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Introduction
Pseudomonas aeruginosa is a versatile Gram-negative rod with a relatively large genome of
more than 6 million base pairs that can thrive in many different niches[1]. P. aeruginosa chron-
ically infects the lungs of patients with cystic fibrosis (CF) and lung deterioration due to inflam-
mation is the major cause of death in these patients[2]. More than half of the CF patients
become chronically infected during their lifetime and most chronically infected patients harbor
the same P. aeruginosa strain for many years or even life-long[3–5]. Several studies have inves-
tigated adaptation of P. aeruginosa trying to understand what the essential factors are for colo-
nization and persistence in the lungs of CF patients despite the host immune system and
aggressive antibiotic treatment[2;6–13]. Genome analysis of P. aeruginosa demonstrated that
genes involved in biofilm formation, motility, transmembrane transport, hemolysis, secretion
systems and resistance to oxidative stress and antibiotics are associated with CF lung adapta-
tion [6]. Adaptation is mediated through remodeling of regulatory networks involving central
metabolism and pathogenicity[13]. Phenotypic adaptation often involves a reduced growth
rate, loss of motility, loss of substantial catabolic activities and inactivation of important regula-
tory functions[14]. Several studies demonstrated that parallel evolutionary events in these
adapted strains do not seem to be due to loss or gain of certain genes[15], but rather to patho-
adaptive mutations[10;13;16]. However, some CF adapted strains share accessory genomic ele-
ments like the LES-prophage-1, LESGI-2, and LESGI-4, that may contribute to increased com-
petitiveness in the CF lung[17]. Adapted strains can be transmitted between CF patients and
some of these epidemic P. aeruginosa clones seem associated with worse clinical outcome[18–
23]. In the Netherlands, an epidemic P. aeruginosa clone with MLST type ST406, MLVA type
CC27 and AT-chip single nucleotide polymorphism (SNP)-type A418 or E418 was found in up
to 50% of CF patients between 15 and 25 years of age in 2007[24–26]. This clone was not found
in clinical cultures from non-CF patients and was genotypically different from the epidemic CF
strains found in other countries[26;27]. SNP-typing of clinical and environmental P. aerugi-
nosa strains from all over the world only detected this genotype in Dutch CF patients[28]. The
fact that this clone is specifically linked to the CF lung niche suggests that this genotype is very
well adapted to the CF lung. In contrast to some other epidemic clones an association with clin-
ical deterioration could not be detected for ST406[29]. Another clone (ST497) was found in 5%
of Dutch CF patients and was associated with older age (>25 years)[25]. Likewise this genotype
has thus far only been isolated from Dutch CF patients.
Insights into the evolutionary dynamics during chronic colonization of the lungs of CF
patients and genetic relatedness of epidemic CF clones that are specifically adapted to the cystic
fibrosis lung niche might give further clues for new eradication therapies or preventive mea-
sures. The aims of this study were to infer the phylogenomic relatedness of two high-prevalent
P. aeruginosa clones in the Netherlands, ST406 and ST497, to a collection of P. aeruginosa
strains and to describe genotypic and phenotypic changes of ST406 during adaptation to the
CF airway and compare this to other known CF clones. To investigate the traits that may have
contributed to adaptation of the P. aeruginosa ST406 clone to the CF lung we indexed genome-
wide alterations by performing comparative genomics in combination with comparative tran-
scriptomics and cataloging phenotypic differences between two ST406 strains obtained from
the same patient, but separated by a timespan of three years. The first isolate was cultured one
month after the patient became first colonized with P. aeruginosa (“early isolate” or S1) while
the second isolate was recovered from the same patient after three years of chronic colonization
(“late isolate” or S2).
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Methods
Strains
The first, early, P. aeruginosa ST406 isolate (S1) was cultured from sputum from a 15 years old,
Dutch CF patient in 2004, one month after the very first detection of P. aeruginosa in this
patient. This patient became chronically infected after the first positive culture in 2004. The
second, late, P. aeruginosa ST406 isolate (S2) was cultured in 2007 from sputum from the same
CF patient. Both isolates were non-mucoid phenotype. ST497 isolate (S3) was cultured from
another 26 year old, Dutch CF patient that had already been chronically infected with P. aeru-
ginosa for more than seven years. Both patients were regularly visiting the University Medical
Centre in Utrecht for their regular medical care. P. aeruginosa strain PA01 and E. coli strains
that harbor lasB-gfp (MH155) or rhlA-gfp fusion for quorum sensing detection were kindly
provided by Søren Molin from DTU, Denmark.
Whole genome sequencing and SNP analysis
Genomic DNA was extracted from P. aeruginosa isolates S1, S2 and S3 using a Wizard Geno-
mic DNA Purification kit (Promega). Whole genome sequencing was performed on an Illu-
mina MiSeq platform. Raw 2×250 bp paired-end Illumina reads were quality-filtered using
Nesoni 0.109 [https://github.com/Victorian-Bioinformatics-Consortium/nesoni] (with follow-
ing options: adaptor-clip (yes), adaptor-match (10), adaptor-match max error (1), clip ambigu-
ous (yes), quality cutoff (10), minimum read length (150)). De novo assembly was done using
SPAdes 2.5.1[30]: kmers used (21, 33, 55, 77, 99, 127), with “careful” option turned on and cut-
offs for final assemblies: minimum contig/scaffold size = 500 bp, minimum contig/scaffold
average Nt coverage = 10-fold. Gene prediction and annotation was done using Prokka[31]
(default options; using a Pseudomonas-specific BLAST database, as provided in the Prokka
package) and RAST[32]. Additional functional annotation of protein-coding genes was done
using the COG database[33]. Protein sequences were queried against the COG myva database
using BLAST 2.2.29+[34] and received the same COG as their best BLAST hit (E-cutoff 1e-
10). Sequencing reads have been submitted to the European Nucleotide Archive under study
PRJEB12885.
To compare differences between the ST406 S1 and S2 isolates and investigate within-patient
adaptation an in-house read-mapping pipeline was used to detect SNPs and small indels.
Nesoni-filtered reads of S2 were mapped against the S1 assembly using Bowtie2[35]. To filter
for genomic repeats, we removed reads that mapped to multiple positions in the S1 assembly.
SAMtools 0.1.18[36] was used to call SNPs and indels with following conditions: Qscore 50,
mapping quality 30, and calls were required to be homozygous (under diploid model). Addi-
tional criteria included a mapping depth 10 reads, a consensus of 75% to support a call,
and 1 supporting read in each direction. To correct for potential assembly errors, we also
performed the SNP/indel-calling procedure described above after mapping Nesoni-filtered
reads of S1 against its own assembly. Genomic positions containing SNPs and indels in the S1
vs S1 comparison were ignored in the S2 vs S1 comparison. Identified SNPs and indels were
linked to features (i.e. genes) and were inspected for synonymous vs non-synonymous muta-
tions (in case of SNPs).
To compare gene content between S1 and S2 we used Inparanoid v4.129. All S1 genes that
did not have a predicted orthologous relationship with an S2 gene and vice versa were consid-
ered as potentially unique for that given strain. To further verify these potential strain-specific
genes, S2 reads were mapped against the S1 assembly and vice versa as described above, but
without filtering for reads mapping to multiple genomic positions. Using the same criteria
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described above for finding SNPs and small indels, genomic regions significantly covered by
mapped reads were identified. Potentially strain-specific genes identified using Inparanoid
were considered to be truly strain-specific if 10% of their entire length was covered by reads.
Core genome alignment
To investigate phylogenetic relatedness of the three P. aeruginosa isolates from Dutch CF
patients that represent two prevalent Dutch clones with an international collection of P. aerugi-
nosa strains all publicly available P. aeruginosa whole genome sequences (WGSs) were down-
loaded from GenBank on 12 February 2014. The genome sequences of these publicly available
strains and of strains S1, S2 and S3 were aligned using an in-house pipeline that makes use of
the NUCmer v3.23 alignment algorithm[37]. All genomes were aligned against the completed
genome sequence of P. aeruginosa PA01 (i.e. used as reference strain). Repetitively aligning
genomic regions were removed from each pairwise alignment after which all pairwise align-
ments were merged into one P. aeruginosa core genome alignment. A phylogenetic tree was
built from the polymorphic sites in the core genome alignment using RAxML[38]. The tree
was built under the GTR model. Confidence was inferred by running 1000 bootstrap replicates
under the same model. The tree was visualized using MEGA6[39]. Odds ratio’s for calculating
significance of associations between source (CF sputum isolate, clinical isolate, or environmen-
tal isolate) and clade assignment was done using MedCalc software (https://www.medcalc.org/
calc/odds_ratio.php). The P-value threshold for statistical significance was set at 0.05.
Transcriptome analysis
Transcriptome analysis using GeneChip P. aeruginosa genome arrays (Affymetrix) was per-
formed as described previously[14]. P. aeruginosa strains were grown aerobically in Luria-Ber-
tani (LB) medium starting from OD600 = 0.01 and harvested at OD600 = 0.5. RNA was
isolated using RNeasy Mini Purification kit (QIAGEN) and transcribed into cDNA using ran-
dom primers (Invitrogen Life Technologies). Subsequently, cDNA was purified (QIAquick,
QIAGEN), fragmented and labeled and hybridized on an Affymetrix P. aeruginosa PA01 gene
chip. The probe arrays were scanned with a GeneChip Scanner 3000 and the raw data was
obtained using the Affymetrix GeneChip Operating System 1.4. Microarray data analysis was
performed as described before[24] using bioconductor in R environment (http://www.
bioconductor.org). Normalization and expression index calculation was done with rma func-
tion[40]. The fold change was calculated using the average expression levels of three replicates.
A cut off p-value< 0.05 and fold change> 2 between transcriptome levels of S1 and S2 was
considered significant. The annotations and functional classes were assigned according to the
Pseudomonas Genome Database[41].
Amplification of S2 specific genes
To verify differences in gene content between S1 and S2 (detected by comparing whole genome
sequence data as described above) and analyze presence of these genes in other Pseudomonas
aeruginosa isolates we performed PCR amplification in 29 non-ST406 clinical isolates (6 ICU,
6 community acquired, 6 CF, 6 other clinical isolates from a previous study[26] and 3 isolates
of the Liverpool epidemic PA01 and the Midlands epidemic strain) (S1 Table). Isolates were
cultured on tryptic soy agar (TSA)-blood plates (Becton, The Netherlands) overnight at 37°C,
suspended in 20 μl lysis buffer (0.25% (wt/vol) SDS, 0.05 N NaOH) and incubated at 95°C for
20 min. The cell lysate was centrifuged and diluted with 180 μl buffer (10 mM Tris-HCl, pH
8.5). After thoroughly mixing, another centrifugation for 5 min at 16,000 x g was performed to
remove cell debris. Supernatants were frozen at -20°C until further use. Two μl of the lysate
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was used in a touchdown PCR using Hotstar Taq DNA polymerase (Qiagen Benelux B.V.),
and 5 μl Q-buffer (Qiagen Benelux B.V., Venlo, the Netherlands). The PCR was conducted as
follows: 10 min at 96°C, then 10 cycles of 30 s at 95°C, 30 s at 65°C with 1°C less every cycle
and 1 min at 72°C. This was followed by 25 cycles of 30 s at 95°C, 30 s at 55°C and 1 min at
72°C, after which the final step of 10 min at 72°C followed. Presence of PCR products was
checked by electrophoresis on 1% (wt/vol) agarose gel. S2 was used as positive control. Primers
used for PCR amplification of S2 specific genes and non-ST406 P. aeruginosa strains used to
test presence of these genes are shown in S1 Table.
Phenotypic experiments
Phenotypic traits known to be important virulence factors that are involved in adaptation to
chronic infection of the CF lung are growth rate, excreted proteases, motility, quorum sensing
and biofilm formation were compared between S1 and S2. PA01 was used as control.
Motility assays. Swimming, swarming and twitching motility and protease assays were per-
formed in triplicate. Bacteria were grown overnight on LB agar plates. Swimming, swarming and
twitching motility assays were performed on respectively 0.3% (wt/vol), 0.6% (wt/vol) and 1.5%
(wt/vol) agarose plates containing Agrobacterium (AB) minimal medium with glucose (0.5%(wt/
vol)) and casamino acids (0.5% (wt/vol)). One bacterial colony was inoculated in, on and through
the agar by sterile toothpick, respectively. Swimming ability was assessed after 24 h incubation at
30°C by measuring the maximum diameter of the zone of growth. Swarming and twitching was
assessed after 48 h of incubation at 37°C by measuring zones of growth. Protease production in
skimmilk was measured by inoculating 100 μl of supernatant of overnight culture (after spinning
at 7000 g for 5 min) on a LB-agar plate with 10% (wt/vol) skim milk concentration. Clear zones
of protease production were measured after 48 h of incubation at 37°C.
Growth curves. Growth curves were made by measuring OD600 every 50 min, starting
with an OD600 of 0.01. Doubling time was calculated in Microsoft Excel using the exponential
trend line (tD = (ln2/μ)).
Quorum sensing. Quorum sensing signal production was tested by streaking isolates and
a positive and negative control near two E. colimonitor strains that harbor lasB-gfp (MH155)
or rhlA-gfp fusion products on a plasmid[42] that can be induced by the Las (3-O-C12-HSL)
and Rhl signal molecule (C4-HSL), respectively. GFP (green fluorescent protein) production
was visualized after 24 hincubation at 37°C using a Zeiss Axion2 microscope with an integrated
Coolsnap color cf camera at 2.5x magnification and 200ms exposure time.
Phenotype MicroArrays. To investigate difference between S1 and S2 in growth under
conditions using different nutritional sources and other chemical compounds like toxins, phe-
notypic microarrays were performed. Quantitative measurements of 1821 phenotypes of S1, S2
and of P. aeruginosa strain PA01 were determined using phenotype MicroArrays (Biolog, Inc
Hayward CA, USA). In this assay cell respiration, measured by color change caused by reduc-
ing a tetrazolium dye, is used as a universal reporter for both amplification and precise quanti-
tation of phenotypes. The measured average height of two replicates of each phenotype was
compared between S1 and S2. Phenotypes with more than two-fold difference were considered
different phenotypes. Among the 1821 phenotypes tested by this method were 190 Carbon-
sources, 384 Nitrogen-sources, 60 Phosphor- sources, 192 phenotypes related to osmolytes and
pH and 960 to chemical sensibility.
Antibiotic susceptibility and colony morphology. Susceptibilities were determined by
disk diffusion on Muller Hinton plates using EUCAST breakpoints for ciprofloxacin, levofloxa-
cin, piperacillin, ceftazidime, tobramycin, amikacin, meropenem, piperacillin/tazobactam,
colistin trimethoprim, trimethoprim/sulfamethoxazole, chloramphenicol.
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Colony morphology was checked under the plate microscope.
Biofilm experiments. A semi-static biofilm model was used to assess biofilm formation of
S1 and S2, as described before[43]. Overnight bacterial cultures were diluted to an OD660 of
0.01 in 6 ml LB medium with 1%(wt/vol) glucose and added to a coverslip coated with poly-L-
lysine (0.45 μm; diameter, 12 mm; Becton Dickinson) inside a well from a six-well polystyrene
plate (Corning Inc.). Biofilms were grown at 30°C for 48 hat 120 rpm. After 48 h, the coverslips
were washed with 0.85% (wt/vol) NaCl and the biofilms were chemically fixed with 8% (vol/
vol) glutaraldehyde (Merck) for 20 min. Subsequently, the biofilms were stained with 15 μg/ml
propidium iodide (PI) in 0.85% (wt/vol) NaCl that was removed after 15 min. The coverslips
were transferred to glass microscope slides and analyzed by a confocal laser scanning micro-
scope (CLSM) (Leica SP5), equipped with an oil plan-Neofluar ×63/1.4 objective. PI was
excited at 488 nm. Z stacks were taken with an interval of 0.42 μm. Pictures were analyzed with
LAS AF software (Leica), and biofilm thickness and biomass were quantified using Comstat
[44]/Matlab R2013b software (the MathWorks). The average thickness and biomass of the bio-
films were measured at ten randomly chosen positions and statistical significance determined
by unpaired two-tailed Student's t-test. Experiments were performed twice in duplicate.
Results and Discussion
Whole genome sequencing and phylogenetic inferences
To determine the phylogenetic relationship between Dutch prevalent clones, ST406 (S1 and
S2) and ST497 (S3), and other epidemic clones whole genome sequencing was performed. Illu-
mina sequencing and subsequent assembly of the three P. aeruginosa isolates S1, S2 and S3
yielded draft genomes with an average assembly size of 6.32, 6.32, and 6.28 Mbp, consisting of
45, 42, and 48 scaffolds with a nucleotide coverage of 56.4, 55.9 and 81.1, respectively. To assess
the phylogenetic relatedness of the two Dutch epidemic clones, represented by the three P. aer-
uginosa isolates from Dutch CF patients S1, S2 and S3, with an international collection of P.
aeruginosa strains, publicly available genome sequences of 37 P. aeruginosa strains were down-
loaded and aligned together (S2 Table). This resulted in a core genome alignment of 3.27 Mb,
containing 258,000 SNPs. An initial SNP-based phylogenetic tree showed that strains PA7 &
VRFPA01 clustered far away from the other P. aeruginosa strains. To increase resolution, PA7
& VRFPA01 were left out and the remaining 38 strains were re-aligned. Identical strains were
removed from the tree for clarity (MPA01P1, MPA01P2 and PA0579 represented by PA01 and
PADK2CF510 represented by DK2). The final core genome alignment was 4.02 Mb and a phy-
logenetic tree including 34 strains was constructed using the 121,244 SNPs contained in this
alignment (Fig 1).
The phylogenetic tree demonstrated that the Dutch high-prevalent P. aeruginosa CF strains,
S1/S2 and S3 were evolutionary not closely related to other epidemic CF related clones. Also
the Liverpool epidemic strain clustered separately, while the Manchester and Danish epidemic
CF strain shared a common ancestry. Two distinct clades (A and B) were identified in the tree,
which contain both environmental and clinical isolates as well as isolates from CF patients.
However, clinical non-CF isolates were significantly associated with clade B (OR: 8.0; 95% CI:
1.5–43.7; p<0.01), while CF isolates were enriched in clade A, although this was not significant
(OR: 7.4; 95% CI: 0.8–68; p = 0.08). Even though, there seems to be a trend towards significance
and a larger number of isolates would be required to investigate the finding further and these
results could suggests that clinical non-CF isolates may have an evolutionary background that
is distinct from isolates colonizing CF patients. Of course, numbers of strains in our study are
relatively small, and selection of strains that were chosen for WGS might contain a bias.
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In contrast to these observations, several studies investigating both clinical and environ-
mental isolates have demonstrated that P. aeruginosa has a non-clonal epidemic population
structure with no clear association between specific lineages and certain niches[23;28;45–50].
However, these studies indexed only a limited number of loci providing limited power for
Fig 1. Phylogenetic tree including 34 P. aeruginosa strains built from an alignment of 121k core SNPs.Numbers along the branches indicate
bootstrap values and only bootstrap values75% are shown. Branch lengths correspond to the scale bar, in units of changes/nucleotide position.
Green = CF sputum isolate, red = clinical isolate, not CF, blue = environmental isolate. The Dutch high-prevalent CF strains and internationally known
epidemic CF strains have been indicated.
doi:10.1371/journal.pone.0158106.g001
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inferring phylogenetic relationships. The fact that not all epidemic CF isolates group in one
lineage indicates that these CF isolates do not form one monophyletic group, thus do not share
a recent common ancestor. Clearly, the Manchester, Danish, Liverpool, and both Dutch epi-
demic CF strains form a polyphyletic group in which phylogenetically different sequences have
converted into a successful epidemic phenotype in CF patients.
Comparative genomics and transcriptomics of the early (S1) and late
(S2) ST406 isolate
To investigate genomic differences between S1 and S2, 6,284,869 bases (99.4–99.5% of total
assembly size) of the two isolates were aligned and this yielded 42 high quality SNPs and 10
indels. Twelve SNPs were synonymous, while 24 were non-synonymous (Table 1). Five SNPs
were located in intergenic regions and one occurred in an rRNA encoding gene. Most (29%)
non-synonymous mutations were in genes coding for COG categories involved in metabolism,
followed by non-synonymous SNPs in COG category transcription and signal transduction
(21%) and category unknown (25%) (Fig 2).
Metabolic alterations and changes in regulatory functions have also been described for
other CF adapted clones[13]. Whole genome sequencing of various isolates from different CF
patients that harbored the DK2 clone for many years revealed loss of catabolic activities and
inactivation of important regulatory systems[14]. Furthermore, analysis of non-synonymous
SNPs in core genes of 32 CF related strains including LES (Liverpool epidemic strain) isolates
revealed SNPs in genes encoding proteins involved in oxidoreductase activity, secretion and
heterocycle metabolism[6].
Comparative transcriptomics between ST406 S1 and S2 yielded 179 genes with different
transcription levels (p< 0.05), of which 110 genes had a more than 2-fold difference in gene
expression (S3 Table). Gene ontology enrichment analysis revealed overrepresentation of dif-
ferentially expressed genes involved in metabolism and posttranslational modification that
were higher expressed in S1 and genes encoding membrane proteins or involved in membrane
or cell wall biogenesis and proteins involved in secretion that were higher expressed in S2 (Fig
3). Approximately 92% of all the genes in strains S1 & S2 were covered by uniquely and per-
fectly matching probes on the Affymetrix P. aeruginosa PA01 GeneChip when using a cutoff of
at least 4 probes per gene (~96% in PAO1). This indicates that only a small proportion of S1
and S2 genes was not analyzed for transcription differences.
All SNPs were located in genes that have been previously described in adaptation of P. aeru-
ginosa to the lung of CF patients and of which some were designated pathoadaptive genes
(Table 1). These SNPs were in the same genes but not identical to other published SNPs. SNPs
and transcriptome differences between S1 and S2 in genes that were deemed important for
observed phenotypic differences are described in more detail below.
Recent studies have shown that in one sputum sample of a CF patient a variety of P. aerugi-
nosa isolates of the same genotype with variable phenotypes and based on WGS data several
SNPs can be detected[7;13;51–53]. This suggests that in these niches P. aeruginosa behaves as a
quasispecies, i.e. a large group or cloud of related genotypes that exist in an environment of
high mutation rate[54]. This adaptive radiation can explain why in various longitudinal studies
in CF patients, in addition to common parallel evolutionary events in chronically colonizing P.
aeruginosa isolates, also different unique sets of putative adaptive SNPs and phenotypes have
been identified.
ExsA and the type III secretion system (T3SS). A non-synonymous SNP (change from
P156L in isolate S2) was identified in exsA (Table 1). Furthermore, one nucleotide insertion
was detected upstream in the promoter region of this gene (Table 2). ExsA is a member of the
Within-Host Evolution of Pseudomonas aeruginosa Clone
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Table 1. 24 non-synonymous SNPs detected between early (S1)and late (S2) ST406 isolate.
ST 406
gene
SNP [aa
change]a
amino acid
position
PA01
annotation
gene COG function classiﬁcation SNP in same gene
in literature
3848 AAC[N] > ATC
[I]
63 PA3545b algG Inorganic ion transport and metabolism [9], [13], [14], [53]
5027 AAC[N] > ATC
[I]
178 PA4102 bfmS Signal transduction mechanisms [13], [14]
3581 AAG[K] >
GAG[E]
297 PA1782 General function prediction only, Signal transduction mechanisms,
Transcription, Replication, recombination and repair
[13]
5598 AAT[N] > GAT
[D]
41 PA4276 secE Intracellular trafﬁcking, secretion, and vesicular transport [13]
5091 ACC[T] >
GCC[A]
460 PA4039 Cell motility [13]
1522 ACG[T] >
GCG[A]
1063 PA2727
+ PA2728
Replication, recombination and repair [13]
4626 AGC[S] >
AGA[R]
224 PA2385b pvdQ General function prediction only [13]
4879 ATC[I] > AGC
[S]
3973 PA0690 secretion [13], [14]
0345 ATC[I] > GTC
[V]
456 PA1147 Amino acid transport and metabolism [13]
2241 ATG[M] >
AAG[K]
86 PA4519 speC Amino acid transport and metabolism [9]
3651 CCG[P] >
CTG[L]
156 PA1713 exsA Transcription [8],[9],[10], [13], [53]
5490 CTG[L] > ATG
[M]
30 PA4163 Translation, ribosomal structure and biogenesis [13]
0807 GCC[A] >
ACC[T]
703 PA0794 Energy production and conversion [13]
3973 GCC[A] >
GGC[G]
61 PA3280 oprO Inorganic ion transport and metabolism [13]
5588 GCC[A] >
GTC[V]
489 PA4266b fusA1 Translation, ribosomal structure and biogenesis [10], [13], [53]
2194 GCG[A] >
GTG[V]
15 PA4562 General function prediction only [13]
0321 GGC[G] >
GTC[V]
118 PA1171 Cell wall/membrane/envelope biogenesis [13]
4666 GTC[V] > ATC
[I]
204 PA2346 Lipid transport and metabolism [13]
4610 GTC[V] >
GCC[A]
1523 PA2402 Secondary metabolites biosynthesis, transport and catabolism [13]
4794 GTC[V] >
GCC[A]
80 PA2552 Lipid transport and metabolism [13]
2089 TAG[stop]
>TGG[W]
51 PA4661 pagL no COG [13], [14]
4856 TTC[F] > TTG
[L]
34 PA2492b mexT Transcription [8], [13]
0194 TTG[L] > TTT
[F]
68 PA1300 Transcription [13]
5101 TTG[M] >
CTG[L]
213 PA4029 Function unknown [13]
a A = Alanine, D = Aspartic acid, E = Glutamic acid, F = Phenylalanine, I = Isoleucine, K = Lysine, L = leucine, M = methionine, N = asparagine,
P = proline, R = arginine, S = serine, T = treonine, V = valine, W = tryptophan. SNPs are indicated within their codon context, in the order: codon-
S1 > codon-S2.
b pathoadaptive gene by Marvig et al or Winstanley et al.[10;51]
doi:10.1371/journal.pone.0158106.t001
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AraC family of transcriptional regulators and is the primary regulator of the type III secretion
system (T3SS). ExsA controls expression of genes implicated in T3SS biogenesis by directly
binding to promoter sequences of these genes leading to activation of transcription[55]. In cor-
respondence with these findings, our transcriptome analysis indicated differential expression
of T3SS genes, with a significantly lower level of expression in isolate S (S3 Table). Also exoS,
encoding the ExoS toxin, which is secreted by T3SS was expressed at a lower level in S2. Type
III secretion mediated translocation of exoenzymes is used by P. aeruginosa to deliver exoen-
zyme effector molecules, like ExoS, into the eukaryotic cell. Our findings of higher expression
of genes encoding T3SS in S1 relative to S2 suggest that T3SS may play an important role in
acute CF infection but not or to a lesser extent during chronic infection. This is consistent with
previous findings that also demonstrated down regulation of ExoS in chronically infected CF
patients[56]. On the other hand, a recent report also found up-regulation of exoS during
chronic infections[57]. These conflicting data indicate that further studies are needed to eluci-
date the exact role of ExoS during acute and chronic infections.
MexT, the MexEF efflux pump and the type VI secretion system (T6SS). Another non-
synonymous SNP (change from F34L in isolate S2) was located inmexT, which encodes the
transcriptional regulator MexT that positively regulates the MexEF-OprN efflux pump and
negatively regulates genes encoding T6SS[58–61] (Table 1). Transcriptome analysis revealed
that themexEF genes encoding the MexEF efflux pump were expressed at a higher level in the
early S1 isolate, while genes encoding T6SS were expressed at higher levels in S (S3 Table). This
suggests that the non-synonymous mutation inmexT affects some of the effector functions of
MexT. The Mex E/F-oprN efflux operon also confers resistance to quinolones, chlorampheni-
col and trimethoprim. Down-regulation ofmexEF genes in S2 coincided with less resistance
against chloramphenicol and trimethoprim/ sulfa-methoxazole, while both isolates are resis-
tant to quinolones and trimethoprim (S4 Table). It is interesting to note thatmexT has been
described as a mutational “hot spot,” where mutations can contribute to global phenotypic
changes in P. aeruginosa[62].
Fig 2. COG categories of non-synonymous SNP differences found between S1 (early isolate) and S2 (late isolate) isolated three years apart from
the same patient. Percentage per category of total non-synonymous SNPs is indicated.
doi:10.1371/journal.pone.0158106.g002
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MigA, PagL and LPS. The early and late isolates displayed different colony morphology
with a rougher colony morphology of S2 compared to S1 (Fig 4). Interestingly, a single nucleo-
tide deletion in S2 relative to S1 and a non-synonymous SNP were detected in two genes,migA
and pagL respectively, implicated in lipopolysaccharides (LPS) biogenesis. Furthermore, S2
contains a single nucleotide deletion just downstream of pagL, which may explain the observed
differences in colony morphology (Tables 1 and 2). ThemigA gene encodes an Alpha-
Fig 3. Functional categories of up- and down-regulated genes in S2 relative to S1 detected with Affymetrix transcriptome analysis. A,
indicates the percentage of genes per COG category that were higher expressed in S2 compared to S1, while B, indicates the percentage of
genes per COG category that were lower expressed in S2 compared to S1. COG category is indicated between brackets.
doi:10.1371/journal.pone.0158106.g003
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1,6-rhamnosyltransferase involved in producing uncapped core oligosaccharide[63] while
pagL encodes a lipid A 3-O-deacylase, which recognizes either 3-OH C10 or 3-OH C14 moie-
ties of the lipid A component of LPS and adjusts the structure of lipid A. Mutations in genes
affecting LPS biogenesis have also previously been described in P. aeruginosa during CF lung
adaptation[9;10;14]. In P. aeruginosa isolates from CF respiratory infections the O-antigen is
not produced in high amounts. Since O-antigen is highly immunogenic this adaptation possi-
bly facilitates chronic persistence[12]. PagL is overexpressed in P. aeruginosa isolates isolated
from CF infants compared to those from acute infections or environmental isolates. However,
it has also been shown before that in chronic infection with severe lung disease PagL function
is lost[64]. Together with our findings this indicates that LPS is under selective pressure in the
CF lung and that LPS modifications contribute to adaptation of P. aeruginosa to the CF airway.
Biofilm formation and comparison of other phenotypic differences
Analyzing biofilm formation of S1 and S2 demonstrated that, in a semi-static model of biofilm
formation, S1 forms significantly thicker biofilms with more biomass than S2 (Fig 5). This
coincides with lower expression levels of bfmR and bfmS genes (S3 Table) in S2. BfmS is part of
the two-component regulatory systems named BfmR/S (PA4101/PA4102) that regulates bio-
film maturation in P. aeruginosa. BfmR/S has been described as essential for biofilm matura-
tion in P. aeruginosa by limiting bacteriophage-mediated lysis and thus, eDNA release[65;66].
Other research indicates that BfmS controls the Rhl quorum-sensing system by repressing
BfmR, which directly reduces production of quorum-sensing molecules (C4-HSL) by suppress-
ing expression of rhlR. Deletion of bfmS causes substantially reduced virulence in lettuce leaf,
reduced cytotoxicity, enhanced invasion, and reduced bacterial survival during acute mouse
lung infection[67]. However, BfmS is able to switch its function from repressor of BfmR to acti-
vator through point mutations found in CF-related strains such as the Danish epidemic clone
(DK2)[67]. This suggests that under certain conditions reduced expression BfmS and BfmR
may indeed coincide with the observed reduced biofilm maturation in S2 relative to S1.
At this moment, however, we can only speculate why loss of biofilm maturation is beneficial
in the CF lung. Also, in vitro experiments with surface-attached biofilms may not reflect in the
in vivo situation in CF lungs. It has been reported before that other “cooperative traits” like
Table 2. Indels in isolate S2 relative to isolate S1.
Indel in S2 PA01
annotation
gene Gene product annotation
GC > GCC (+1C) PA1302 putative heme utilization protein
GGC > GCGGTCCTGCAACTGC (+13CGGTCCTGCAACT) PA4967 parE topoisomerase IV subunit B
GCTGCGGCGC > GCTGCGGCGCGGCCGCCTGCGGCGC
(+15CTGCGGCGCGGCCGC)
PA2727 histidine kinase
TGGG > TGG (-1G) PA4661 downstream of
pagL
lipid A 3-O-deacylase
GGGT > G (-3GGT) PA4379 methyltransferase domain-containing
protein
TGGTAGGTA > TGGTA (-4GGTA) PA3806 putative Fe-S-cluster redox enzyme
TGCCGGCCG > TGCCG (-4GCCG) PA0347 downstream of
glpQ
glycerophosphoryl diester
phosphodiesterase
T > TG (+1G) PA1713 upstream of exsA AraC family of transcriptional
regulators
GT > G (-1T) PA2172 putative cellulase
CT > C (-1T) PA0705 migA alpha-1,6-rhamnosyltransferase
doi:10.1371/journal.pone.0158106.t002
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secretion of pyoverdin, elastase, protease and some quorum-sensing molecules are also down-
regulated in chronic CF isolates, indicating loss of social behavior of isolates that profit from
products produced by cooperative strains[68]. In their study, Jiricny and co-workers did not
observe that loss of social behavior also resulted in lower-level biofilm formation, but possibly
reduced biofilm formation is advantageous at certain stages of chronic infection of the CF lung
by saving energy or increasing transmissibility.
Directly adjacent to bfmRS is a cluster of 5 genes (PA4103-PA4107) that is, like bfmRS, also
significantly lower expressed in S2 (Fig 6). It is known that BfmR directly binds to its own and
to the promoters of PA4107, PA4103, and rhlR and that expression of the operons
PA4103-Pa4104 and PA4105-PA4107 is upregulated in CF lungs due to BfmRS activation[67].
The function of these genes is largely unknown with the exception of PA4107, which was
recently renamed efhP and found to be important for Ca2+ homeostasis and virulence[69]. Lev-
els of Ca2+ are increased in CF lungs[70] and in the presence of high Ca2+ strains lacking func-
tional EfhP were unable to produce pyocyanin, developed less biofilm, and had decreased
resistance to oxidative stress (H2O2).
Besides differences in colony morphology and biofilm formation as described above, other
phenotypic characteristics like swimming, swarming, twitching, production of quorum-sensing
molecules and growth rate were comparable between S1 and S2 (Table 3). Protease production
was slightly higher in S2. Both strains displayed a slow growing phenotype with lack of motility
and lower protease production, compared to PA01. This is something that was also reported
for other CF adapted strains[68;71;72]. Both S1 and S2 did not exhibit a mucoid phenotype,
which is not unexpected. In general, chronically infected CF patients harbor mucoid P. aerugi-
nosa, however, mucoidity can be lost by secondary site mutations and mucoid and non-mucoid
isolates are often found to co-exist in chronic lung infections[73]. Known virulence-associated
phenotypes that are important for P. aeruginosa colonization and infection, like motility and
Fig 4. Colonymorphologies on sheep blood agar. S1 (left) has a smooth colony morphology, while S2 (right) has a more rough colony morphology.
doi:10.1371/journal.pone.0158106.g004
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quorum-sensing are not displayed in both the early and late ST406 isolate. Reduced virulence
in CF adapted strains is also described in other studies[74;75].
To further quantitatively measure phenotypic traits of S1 and S2, growth rates of S1 and S2
were measured on different substrates using Phenotype MicroArrays. Relative to S1, S2 dem-
onstrated enhanced metabolism in the presence of toxic substances like chloride and bromide
detergents, and diverse oxidizing agents, while the S2 isolate displayed decreased growth capa-
bilities on various nutritional supplements like several amino acids and different Carbon
(1,2-Propanediol, Adenosine, D-Arabitol, D-Glucosaminic Acid, D-Glucuronic Acid, L-Alani-
namide), Phosphor (Dithiophosphate, D-Mannose-6-Phosphate, O-Phospho-D-Serine,
Fig 5. Biofilm formation. Biofilm formation in semi-static model of S1 (a) and S2 (b) after 48 h in LB+1% (wt/vol) glucose; Difference in total biomass (c) and
average thickness (d) with Standard deviation error bars. Asterisks represent significant differences (*** P<0.005) as determined by an unpaired two-tailed
Student's t-test.
doi:10.1371/journal.pone.0158106.g005
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O-Phospho-L-Serine) and Nitrogen sources (Fig 7 and S5 Table). This indicated that the tran-
sition from early to late isolate was accompanied with major metabolic changes. Higher expres-
sion of genes involved in metabolism in S1 from transcriptome data matches the phenotypic
microarray data. Metabolic changes have also been described before in chronic CF strains[14].
Differences in gene content between the early (S1) and late (S2) isolate
Annotation of the S1 and S2 genomes revealed 5766 protein-encoding genes in S1 and 5772
protein-encoding genes in S2. This cluster of seven genes in S2 was absent in S1. This means
that either this cluster was acquired by S2 during chronic colonization or that this insert was
already present in the P. aeruginosa (sub-) population at the early time point when strain S1
was sampled. These seven genes encode five hypothetical proteins, a putative replication initia-
tion factor and a phage integrase, suggesting incorporation of phage-associated genes in S2.
This seven-gene cluster is located next to a tRNA-SeC (p)-TCA gene and does not seem to dis-
rupt a coding region or a predicted operon. These features may suggest that this seven-gene
region represents a mobile genetic element, although we have no formal proof for this. On
both sides of the 7 genes there is an identical stretch of 36 bp. This partly overlaps with the
tRNA gene on the 3’ side (Fig 8). PCR performed on three targets of this 7 kb DNA islet respec-
tively including part of predicted genes S2-1398/1399 (893 bp), S2-1401/1402 (426 bp) and S2-
1404 (399 bp), in 29 non-ST406 clinical isolates (6 ICU, 6 community acquired, 6 CF, 6 other
clinical isolates from a previous study[26] and 3 isolates of the Liverpool epidemic strain, PA01
and the Midlands epidemic strain) did not result in a positive PCR product, indicating that this
insertion is specific for the ST406 S2 and, therefore, has probably no general role in adaptation
of P. aeruginosa to the lung of CF patients.
Fig 6. Overview of the gene cluster encompassing genes PA4101-4107.Genes PA4101-4107 are depicted in blue with differences in transcription level
between S1 and S2 and adjacent genes in white. Fold changes in expression level in S1 relative to S2 are indicated underneath. PA4103 is a hypothetical
gene encoding a putative ferric reductase transmembrane component superfamily, PA4104 is a hypothetical gene encoding a polypeptide with similarities to
the DoxX superfamily, PA4105 and PA4106 are hypothetical genes encoding DUF 2063 and DUF 692 superfamily protein, respectively. EfhP is the gene
originally named PA4107. Arrows indicate direction of transcription.
doi:10.1371/journal.pone.0158106.g006
Table 3. Phenotypic traits of S1 and S2 compared to PA01.
phenotypic assay S1 S2 PA01
swim + + ++
swarm - - ++
twitch - - ++
protease + ++ +++
quorum sensing - - +
growth rate (doubling time in min) 50 46 29
doi:10.1371/journal.pone.0158106.t003
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Conclusion
This study characterized genome-wide and phenotypic changes that have occurred in the
Dutch high-prevalent clone ST406 after three years of chronic carriage. The data demonstrate
that within-host evolution of the Dutch ST406 clone within a CF patient during three years
was not driven by major gene acquisition or gene loss, but mostly by point mutations that coin-
cided with differences in transcriptome levels and phenotype, most notably with differences in
biofilm formation. These adaptive evolutionary events in ST406 partly overlap with adapta-
tions described for other chronic CF isolates. In general, clone ST406 seems to have a pheno-
typic profile of low virulence. Drawing firm conclusions on diversification over time are
limited by the fact that in this study only one colony per sputum cultured was used and diver-
sity within the P. aeruginosa population the CF lung at the same time point have been demon-
strated[7;13;51–53]. Since the early isolate was recovered from a CF patient just one month
after first time colonization with P. aeruginosa, diversification at that time was probably low,
but the single late isolate might not capture the full diversity of P. aeruginosa isolates present at
that time point capture the full diversity of P. aeruginosa isolates present at that time point
[53]. The low virulence profile of the early isolate suggests that at the time of isolation it had
already undergone a certain level of adaptation to the CF lung. Common adaptive changes that
are repeatedly found in chronically infecting isolates may provide novel leads for targeted ther-
apeutic interventions to combat chronic colonization with P. aeruginosa in CF patients.
Fig 7. PhenotypeMicroArray analysis of the early (S1) and late (S2) ST406 isolate. Indicated are the Phenotype MicroArray panels for
which at least a two-fold difference in metabolism (= respiration) between S1 and S2 was detected. A, indicate the percentage of
Phenotype MicroArray panels for which the growth rate of S2 was at least two-fold lower than that of S1, while B indicates the percentage
of Phenotype MicroArray panels for which the growth rate of S2 was at least two-fold higher than that of S1. Phenotype MicroArray panel
categories are color-coded and indicated on the right (C = carbon, S = Sulphur, N = Nitrogen, P = Phosphor).
doi:10.1371/journal.pone.0158106.g007
Fig 8. Overview of the seven gene cluster present in the S2 ST406 isolate, but not in the S1 isolate. The 7 kb insert next to tRNAsec and upstream of
gene PA4802 detected only in S2 includes a phage integrase gene (S2-1398) and a gene encoding a putative replication initiation factor (S2-1399) and five
genes encoding hypothetical proteins.
doi:10.1371/journal.pone.0158106.g008
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